Results 241 to 250 of about 227,662 (304)

Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes. [PDF]

Clin Med Insights Endocrinol Diabetes
Abdul Wahab R, Wan Mahmood WA.
europepmc   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity‐Matched Real‐World Analysis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Evidence on cardiovascular/renal outcomes associated with GLP‐1‐based therapies in type 1 diabetes (T1D) is limited. We examined the effects of GLP‐1‐based therapy on major clinical outcomes and safety, including diabetic ketoacidosis (DKA) and hypoglycemia risk, in adults with T1D in a large real‐world cohort.
Anastasios Tentolouris, Charalampos Filippatos, Nikolaos‐Iason Tepetes, Maria Gavriatopoulou, Evangelos Terpos, Alexandros Briasoulis, Kimon Stamatelopoulos, Theodosios Filippatos   +7 more
wiley   +1 more source

Joint Impact of Remnant Cholesterol With Triglyceride Glucose Index in Predicting Outcomes in Statin-Treated Patients. [PDF]

JACC Asia
Zhang HW, Guo YL, Wu NQ, Zhu CG, Xu RX, Dong Q, Dou KF, Li JJ.   +7 more
europepmc   +1 more source

Steroidogenic compensation and lipid deficiency with enhanced NAD+ salvage in small‐for‐gestational‐age placenta

The FEBS Journal, EarlyView.
Fetal growth restriction is associated with placental metabolic adaptations. In small‐for‐gestational‐age placenta (SGA), cholesterol receptors and steroidogenic enzymes are upregulated, enhancing steroidogenesis. NAD salvage pathway is also increased to support NADP+/NADPH requirements.
Serena Xodo, Lorenza Driul, Vanessa Tolotto, Eros Di Giorgio, Luigi E. Xodo   +4 more
wiley   +1 more source

Association Between Statin Use, Cytokine Storm, and Clinical Outcomes in COVID-19 Patients with Diabetes. [PDF]

Biomedicines
Feldi I, Grubišić B, Bačun T, Bosnić Z, Šojat D, Šafer M, Pirić M, Zibar L.   +7 more
europepmc   +1 more source

Statin Therapy and Clinical Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Gillani I, Muneeb Ullah M, Postoev A, Sharma A, Mohammed Abdul RH, Chaudhary S, Gunaratne H, Allahwala D.   +7 more
europepmc   +1 more source

Atorvastatin-Associated Liver Injury: Outcome After Statin Rechallenge. [PDF]

Fundam Clin Pharmacol
Bertin B, Lacotte V, Cracowski JL, Gaiffe A, Dumortier J, Vial T.   +5 more
europepmc   +1 more source

Choosing the Right Non-Statin Therapy for the Right Patient - How To Sequence Advanced Lipid-Lowering Therapies. [PDF]

Curr Atheroscler Rep
Katzmann JL, Laufs U.
europepmc   +1 more source

Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases. [PDF]

Med Sci (Basel)
Commins I, Clayton-Chubb D, Janko N, Majeed A, Kemp W, Roberts SK.   +5 more
europepmc   +1 more source

Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study. [PDF]

BMJ Open Gastroenterol
Brown KA, Gordon SC, Wang Y, Wu T, Trudeau S, Rupp LB, Daida YG, Schmidt MA, Lu M.   +8 more
europepmc   +1 more source